Annual Statements Open main menu

MOBIVITY HOLDINGS CORP. - Quarter Report: 2023 September (Form 10-Q)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to __________

 

Commission file number 000-53851

 

Mobivity Holdings Corp.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   26-3439095
(State or Other Jurisdiction of   (I.R.S. Employer
Incorporation or Organization)   Identification No.)

 

3133 West Frye Road, # 215

Chandler, Arizona 85226

(Address of Principal Executive Offices)

 

(877) 282-7660

(Registrant’s Telephone Number, including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
None   None   None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of November 14, 2023, the registrant had 67,949,709 shares of common stock, par value $0.001 per share, issued and outstanding.

 

 

 

 
 

 

MOBIVITY HOLDINGS CORP.

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION 1
Item 1. Financial Statements 1
Condensed Consolidated Balance Sheets 1
Condensed Consolidated Statements of Operations and Comprehensive Loss 2
Condensed Consolidated Statement of Stockholders’ Deficit 3
Condensed Consolidated Statements of Cash Flows 4
Notes to Condensed Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 18
Item 3. Quantitative and Qualitative Disclosures about Market Risk. 22
Item 4. Controls and Procedures. 22
PART II – OTHER INFORMATION 23
Item 1. Legal Proceedings 23
Item 1A. Risk Factors 23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
Item 3. Defaults Upon Senior Securities 23
Item 4. Mine Safety Disclosures 23
Item 5. Other Information 23
Item 6. Exhibits 23
SIGNATURES 24

 

 
Table of Contents 

 

PART I FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Mobivity Holdings Corp.

Condensed Consolidated Balance Sheets

 

         
   September 30,   December 31, 
   2023   2022 
   (Unaudited)   (Audited) 
ASSETS          
Current assets          
Cash  $457,934   $426,740 
Accounts receivable, net of allowance for doubtful accounts $24,381 and $34,446, respectively   373,980    1,081,183 
Other current assets   241,424    195,017 
Total current assets   1,073,338    1,702,940 
Right to use lease assets   825,041    981,896 
Intangible assets and software development costs, net   78,244    194,772 
Other assets   118,215    137,917 
TOTAL ASSETS  $2,094,838   $3,017,525 
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities          
Accounts payable  $3,492,562   $3,412,612 
Accrued interest   653,431    443,448 
Accrued and deferred personnel compensation   111,610    569,347 
Deferred revenue and customer deposits   218,552    902,727 
Related party notes payable, net - current maturities   2,191,875    2,711,171 
Notes payable, net - current maturities   14,363    32,617 
Operating lease liability, current   269,815    251,665 
Other current liabilities   15,505    49,541 
Total current liabilities   6,967,713    8,373,128 
           
Non-current liabilities          
Related party notes payable, net - long term   3,461,472    2,481,290 
Notes payable, net - long term   29,432    31,092 
Operating lease liability   731,764    936,924 
Total non-current liabilities   4,222,668    3,449,306 
Total liabilities   11,190,381    11,822,434 
           
Stockholders’ deficit          
Common stock, $0.001 par value; 100,000,000 shares authorized; 67,949,709 and 61,311,155, shares issued and outstanding   67,950    61,311 
Equity payable   100,862    324,799 
Additional paid-in capital   117,138,356    108,806,353 
Accumulated other comprehensive loss   22,227    (100,963)
Accumulated deficit   (126,424,938)   (117,896,409)
Total stockholders’ deficit   (9,095,543)   (8,804,909)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $2,094,838   $3,017,525 

 

See accompanying notes to consolidated financial statements.

 

1
Table of Contents 

 

Mobivity Holdings Corp.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 

                 
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Revenues                    
Revenues  $1,633,071   $1,890,437   $5,375,724   $5,787,168 
Cost of revenues   1,160,880    1,806,022   $3,598,661    4,183,719 
Gross profit   472,191    84,415    1,777,063    1,603,449 
                     
Operating expenses                    
General and administrative   2,292,623    983,428    4,907,882    3,088,588 
Sales and marketing   708,398    614,600    2,002,529    1,778,371 
Engineering, research, and development   968,546    784,804    2,507,264    2,360,863 
Impairment of intangible asset       238,143        238,143 
Depreciation and amortization   30,418    118,317    130,902    353,050 
Total operating expenses   3,999,985    2,739,292    9,548,577    7,819,015 
                     
Loss from operations   (3,527,794)   (2,654,877)   (7,771,514)   (6,215,566)
                     
Other income/(expense)                    
Loss of settlement of debt           (10,857)    
Interest expense   (237,376)   (193,501)   (720,265)   (520,454)
Settlement Losses   (13,000)       (25,500)    
Foreign currency gain   (102)   (339)   (393)   2,470 
Total other income/(expense)   (250,478)   (193,840)   (757,015)   (517,984)
Loss before income taxes   (3,778,272)   (2,848,717)   (8,528,529)   (6,733,550)
Income tax expense                
Net loss   (3,778,272)   (2,848,717)   (8,528,529)   (6,733,550)
Other comprehensive loss, net of income tax                    
Foreign currency translation adjustments   91,825    (76,228)   123,190    (76,862)
Comprehensive loss  $(3,686,447)  $(2,924,945)  $(8,405,339)  $(6,810,412)
Net loss per share:                    
Basic and Diluted   (0.06)   (0.05)   (0.13)   (0.12)
Weighted average number of shares:                    
Basic and Diluted   66,785,952    60,297,083    64,878,021    58,544,432 

 

See accompanying notes to consolidated financial statements (unaudited).

 

2
Table of Contents 

 

Mobivity Holdings Corp.

Condensed Consolidated Statement of StockholdersDeficit

(Unaudited)

 

                             
   Common Stock   Equity   Additional Paid-in   Accumulated
Other
Comprehensive
   Accumulated   Total
Stockholders’
Equity
 
   Shares   Dollars   Payable   Capital   Loss   Deficit   (Deficit) 
Balance, December 31, 2021   55,410,695   $55,411   $100,862   $102,446,921   $(52,088)  $(107,835,287)  $(5,284,181)
Issuance of common stock for warrant exercise   3,188,190    3,188        2,547,364            2,550,552 
Issuance of common stock for settlement of interest payable on related party debt               6,201            6,201 
Stock based compensation               589,650           $589,650 
Foreign currency translation adjustment                   (12,895)       (12,895)
Net loss                       (1,933,099)   (1,933,099)
Balance, March 31, 2022   58,598,885    58,599    100,862    105,590,136    (64,983)   (109,768,386)   (4,083,772)
Issuance of common stock for PIPE financing   1,062,500    1,062        848,937            849,999 
Fair market value of options issued with related party debt               48,654            48,654 
Stock based compensation               211,775           $211,775 
Foreign currency translation adjustment                   12,261        12,261 
Net loss                       (1,951,734)   (1,951,734)
Balance, June 30, 2022   59,661,385    59,661    100,862    106,699,502    (52,722)   (111,720,120)   (4,912,817)
Issuance of common stock for PIPE financing   1,500,000    1,500        1,198,501            1,200,001 
Fair market value of options issued with related party debt               18,614            18,614 
Issuance of common stock for settlement of interest payable on related party debt   149,770    150        164,021            164,171 
Stock based compensation               192,959           $192,959 
Foreign currency translation adjustment                   (76,228)       (76,228)
Net loss                       (2,848,717)   (2,848,717)
Balance, September 30, 2022   61,311,155   $61,311   $100,862   $108,273,597   $(128,950)  $(114,568,837)  $(6,262,017)

 

   Common Stock   Equity   Additional Paid-in   Accumulated
Other
Comprehensive
   Accumulated   Total
Stockholders’
Equity
 
   Shares   Dollars   Payable   Capital   Loss   Deficit   (Deficit) 
Balance, December 31, 2022   61,311,155   $61,311   $324,799   $108,806,353   $(100,963)  $(117,896,409)  $(8,804,909)
Issuance of common stock for warrant exercise   3,587,487    3,587        3,583,900            3,587,487 
Issuance of common stock for settlement of interest payable on related party debt   163,757    164   $(7,713)   223,773            216,224 
RSU’s issued - termination of a director’s service   545,012    545        (545)          $ 
Stock based compensation               810,157            810,157 
Foreign currency translation adjustment                   31,502        31,502 
Net loss                      $(2,478,175)   (2,478,175)
Balance, March 31, 2023   65,607,411   $65,607   $317,086   $113,423,638   $(69,461)  $(120,374,584)  $(6,637,714)
Issuance of common stock for settlement of interest payable on related party debt   190,156    191    (9,768)   216,033            206,456 
Stock based compensation               228,577            228,577 
Foreign currency translation adjustment                   (137)       (137)
Net loss                      $(2,272,082)   (2,272,082)
Balance, June 30, 2023   65,797,567   $65,798   $307,318   $113,868,248   $(69,598)  $(122,646,666)  $(8,474,900)
Issuance of common stock for warrant exercise   1,960,976    1,961        1,606,039            1,608,000 
Issuance of common stock for settlement of interest payable on related party debt   191,166    191    (206,456)   206,265             
Fair market value of options issued with related party debt               28,463            28,463 
Stock based compensation               1,429,341            1,429,341 
Foreign currency translation adjustment                   91,825        91,825 
Net loss                      $(3,778,272)   (3,778,272)
Balance, September 30, 2023   67,949,709    67,950    100,862    117,138,356    22,227    (126,424,938)   (9,095,543)

 

See accompanying notes to consolidated financial statements (unaudited).

 

3
Table of Contents 

 

Mobivity Holdings Corp.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

         
   Nine Months Ended 
   September 30, 
   2023   2022 
OPERATING ACTIVITIES          
Net loss  $(8,528,529)  $(6,733,550)
Adjustments to reconcile net loss to net cash used in operating activities:          
Loss on Settlement of Debt - related party   10,857     
Bad debt expense   24,143    45,685 
Stock-based compensation   2,468,075    994,384 
Intangible Asset Impariment       238,143 
Depreciation and amortization expense   162,209    353,050 
Amortization of Debt Discount   89,349    83,334 
Increase (decrease) in cash resulting from changes in:          
Accounts receivable   683,060    (337,347)
Other current assets   9,634    (17,148)
Operating lease assets/liabilities       (15,029)
Other assets   (13,250)    
Accounts payable   79,950    (184,859)
Prepaid Expenses   (46,231)    
Accrued interest   621,806    432,959 
Accrued and deferred personnel compensation   (457,687)   (195,975)
Other liabilities - current   (34,036)   133,167 
Lease Operating Assets   (30,155)    
Deferred revenue and customer deposits   (684,175)   236,827 
Net cash used in operating activities  $(5,644,980)  $(4,966,359)
           
INVESTING ACTIVITIES          
Purchases of equipment   (18,252)   (18,712)
Cash paid for patent activities   (6,300)    
Capitalized software development cost       (12,030)
Net cash used in investing activities   (24,552)   (30,742)
           
FINANCING ACTIVITIES          
Payments on notes payable   (20,004)   (29,145)
Proceeds from Related Party Debt   400,000    800,000 
Proceeds from conversion of common stock warrants   5,195,487    2,550,552 
Proceeds from PIPE funding       2,050,000 
Net cash provided by (used in) financing activities   5,575,483    5,371,407 
           
Effect of foreign currency translation on cash flow   125,243    (92,985)
           
Net Change in cash   31,194    281,321 
Cash at beginning of period  $426,740   $735,424 
Cash at end of period   457,934    1,016,745 
Supplemental disclosure          
Cash paid during period for:          
Interest Paid  $   $ 
           
Fair Value of Options issued with related party debt  $28,463   $73,469 
Shares issued for settlement of debt - related party  $411,823   $161,750 
Shares issued for stock payable for settlement of debt - related party  $223,937   $ 
Par Value pf RSU’s issued - termiation of director’s service  $545   $ 

 

See accompanying notes to consolidated financial statements.

 

4
Table of Contents 

 

Mobivity Holdings Corp.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1. Nature of Operations and Basis of Presentation

 

Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands, and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14, 2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable, and intellectual property. We generate revenue by charging the resellers, brands, and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022

filed with the SEC on April 3, 2023.

 

In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of September 30, 2023, and for the three and nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023.

 

2. Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications did not affect previously reported net losses.

 

Acquisitions

 

We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.

 

Cash

 

We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.

 

Accounts Receivable, Allowance for Doubtful Accounts and Concentrations

 

Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate.

 

As of September 30, 2023, and December 31, 2022, we recorded an allowance for doubtful accounts of $24,381 and $34,446 respectively.

 

Goodwill and Intangible Assets

 

Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.

 

5
Table of Contents 

 

We conducted our annual impairment tests of goodwill as of December 31, 2022. As a result of these tests, we had a total impairment charge of $963,659.

 

Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year to twenty years. No significant residual value is estimated for intangible assets.

 

The Company’s evaluation of its goodwill and intangible assets resulted in no impairment charges for the nine months ended September 30, 2023 and 2022, respectively.

 

Software Development Costs

 

Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the Financial Accounting Standards Board (“FASB”) guidance for the costs of computer software to be sold, leased, or otherwise marketed (Accounting Standards Codification subtopic 985-20, Costs of Software to Be Sold, Leased, or Marketed, or “ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. The technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense.

 

Capitalized costs for those products that are canceled or abandoned are charged to product development expenses in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four-month period.

 

The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development assets resulted in no impairment charges for the three months ended September 30, 2023 and 2022, respectively

 

Impairment of Long-Lived Assets

 

We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.

 

Foreign Currency Translation

 

The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of ASC subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income.

 

Revenue Recognition and Concentrations

 

Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and fees are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue.

 

Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues.

 

We determine revenue recognition under ASC 606 through the following steps:

 

  identification of the contract, or contracts, with a customer;
     
  identification of the performance obligations in the contract;
     
  identification of the transaction price;
     
  allocation of the transaction price to the performance obligations in the contract; and
     
  recognition of revenue when, or as, we satisfy a performance obligation.

 

During the nine months ended September 30, 2023 and 2022, two customers accounted for 52% and 50% of our revenues, respectively.

 

6
Table of Contents 

 

Comprehensive Income (Loss)

 

Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at a comprehensive loss. For the three months ended September 30, 2023 and 2022 , the comprehensive loss was$3,686,447, and $2,924,945 respectively. For the nine months ended September 30, 2023 and 2022, the comprehensive loss was $8,405,339 and $6,810,412 respectively.

 

Stock-based Compensation

 

We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.

 

Research and Development Expenditures

 

Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.

 

Advertising Expense

 

Direct advertising costs are expensed as incurred and consist primarily of trade shows, sales enablement, content creation, paid engagement and other direct costs. Advertising expense was $169,549 and $315,540 for the nine months ended September 30, 2023 and 2022, respectively.

 

Income Taxes

 

We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.

 

Net Loss Per Common Share

 

Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase, and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and nine months ended September 30, 2023 and 2022, we had securities outstanding which could potentially dilute basic earnings per share in the future. Stock based compensation, stock options and warrants were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive.

 

Recent Accounting Pronouncements

 

Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following is a summary of recent accounting developments.

 

In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). ASU 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The Company adopted ASU 2020-06 on January 1, 2022.

 

3. Going Concern

 

We had $457,934 of cash as of September 30, 2023. We had a net loss of $8,528,529 for the nine months ended September 30, 2023, and we used $5,644,980 of cash in our operating activities during that time. In the nine months ended September 30, 2022 we had a net loss of $6,733,550 and used $4,966,359 of cash in our operating expenses. We raised $3.6 million in cash from the exercise of warrants in February of 2023. In addition, we raised $1.6 million in cash from the exercise in August 2023. There is substantial doubt that our additional cash from our warrant conversion along with our expected cash flow from operations, will be sufficient to fund our 12-month plan of operations, there can be no assurance that we will not require significant additional capital within 12 months.

 

As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $126.4 million as of September 30, 2023. Further losses are anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next 12 months with proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

 

7
Table of Contents 

 

4. Goodwill and Purchased Intangibles

 

Goodwill

 

The carrying value of goodwill at each of September 30, 2023 and December 31, 2022 was $0.

 

The following table presents details of our purchased intangible assets as of September 30, 2023 and December 31, 2022:

 

Intangible assets

 

   Balance at
December 31,
2022
   Additions   Impairments   Amortization   Fx and
Other
   Balance at
September 30,
2023
 
Patents and trademarks  $52,698   $6,300   $   $(5,444)  $1,555   $55,109 
Customer and merchant relationships   30,690           $(18,414)       12,276 
Trade names   8,050           $(4,831)       3,219 
   $91,438   $6,300   $   $(28,689)  $1,555   $70,604 

 

The intangible assets are being amortized on a straight-line basis over their estimated useful lives of one year to twenty years.

 

Amortization expense for intangible assets was $28,689 and $107,211 for the nine months ended September 30, 2023 and 2022, respectively, and is included in depreciation and amortization on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss.

 

Amortization expense for intangible assets was $10,747 and $35,724 for the three months ended September 30, 2023 and 2022, respectively.

 

The estimated future amortization expense of our intangible assets as of September 30, 2023 is as follows:

 

Year ending December 31,  Amount 
2023  $9,193 
2024   13,526 
2025   5,778 
2026   5,778 
2027   5,778 
Thereafter   30,551 
Total  $70,604 

 

5. Software Development Costs

 

The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities.

 

The following table presents details of our software development costs as of September 30, 2023 and December 31, 2022:

 

   Balance at
December 31,
2022
   Additions   Amortization   Balance at
September 30,
2023
 
Software Development Costs  $103,334   $   $(95,694)  $7,640 
   $103,334   $   $(95,694)  $7,640 

 

Software development costs are being amortized on a straight-line basis over their estimated useful life of two years.

 

8
Table of Contents 

 

Amortization expense for software development costs was $18,120 and $61,764 for the three months ended September 30, 2023 and 2022, respectively, and is included in depreciation and amortization on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss.

 

Amortization expense for software development costs was $95,694 and $207,027 for the nine months ended September 30, 2023 and 2022, respectively.

 

The estimated future amortization expense of software development costs as of September 30, 2023 is as follows:

 

Year ending December 31,  Amount 
2023  $3,134 
2024   4,506 
2025    
2026    
2027    
Thereafter    
Total  $7,640 

 

 

6. Operating Lease Assets

 

The Company entered into a lease agreement on February 1, 2021, for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $25,953 to $28,733. The first twelve months of the lease included a 50% abatement period and a deposit of $110,000 was required. The lessor contributed $110,000 towards the purchase of office furniture as part of the lease agreement. As of September 30, 2023, we have an operating lease asset balance of $825,041 and an operating lease liability balance of $1,001,579 recorded in accordance with ASC 842, Leases (ASC “842”).

 

The following are additional details related to leases recorded on our balance sheet as of September 30, 2023:

 

Leases  Classification  Balance at
September 30,
2023
 
Assets        
Current        
Operating lease assets  Operating lease assets  $ 
Noncurrent        
Operating lease assets  Noncurrent operating lease assets  $825,041 
Total lease assets     $825,041 
         
Liabilities        
Current        
Operating lease liabilities  Operating lease liabilities  $269,815 
Noncurrent        
Operating lease liabilities  Noncurrent operating lease liabilities  $731,764 
Total lease liabilities     $1,001,579 

 

9
Table of Contents 

 

The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term, and weighted average discount rate: 

 

Year ending December 31,    
2023  $81,194 
2024   330,894 
2025   337,568 
2026   344,241 
2027   28,734 
Thereafter    
Total future lease payments   1,122,631 
Less: imputed interest   (121,052)
Total  $1,001,579 

 

Weighted Average Remaining Lease Term (years)    
Operating leases   3.58 
      
Weighted Average Discount Rate     
Operating leases   6.75%

 

7. Notes Payable and Interest Expense

 

The following table presents details of our notes payable as of September 30, 2023 and December 31, 2022:

 

 

Facility  Maturity  Interest Rate   Balance at
September 30,
2023
   Balance at
December 31,
2022
 
ACOA Note   February 1, 2024       14,363    34,231 
TD Bank   December 31, 2023       29,432    29,478 
Related Party Note   various   15%   5,653,347    5,192,461 
Total Debt           5,697,142    5,256,170 
Less current portion           (2,206,238)   (2,743,788)
Long-term debt, net of current portion          $3,490,904   $2,512,382 

 

ACOA Note

 

On November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014, with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement, the note will mature, and the commitments will terminate on February 1, 2024. The monthly principal payment amount of $3,000 CAD increased to $3,500 CAD beginning on November 1, 2019, $4,000 CAD on August 1, 2021, $4,500 CAD on August 1, 2022, and $2,215 CAD during the remaining term of the agreement. Payments from April-December of 2020 were voluntarily deferred by ACOA due to COVID-19.

 

During the nine months ended September 30, 2023 we repaid $20,004 USD of principal.

 

TD Bank Loan

 

On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $40,000 CAD, which is due and payable on December 31, 2023. This note bears interest on the unpaid balance at the rate of zero percent (0%) per annum during the initial term. Under this note, no interest or principal payments are due until December 31, 2023. Under the conditions of the loan, thirty-three percent (33%) of the loan will be forgiven if sixty-seven percent (67%) is repaid prior to the initial term date.

 

Related Party Notes

 

Secured Promissory Notes

 

On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Agreement was amended on November 11, 2022. The Company can borrow up to $6,000,000 under the Credit Agreement (“the “Credit Facility”).

 

10
Table of Contents 

 

The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this loan without notice, penalty, or charge. In consideration of the Lender’s agreement to provide the Credit Facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under the Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the corresponding notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the Lender additional warrants entitling the Lender to purchase a number of shares of the Company’s common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the “VWAP”). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP.

 

Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. On November 11, 2022, an amendment to the Credit Agreement was signed. The amendment updated the payment terms to the following: “Without limiting the foregoing Section 2.3(a), Borrower shall repay the principal amount of all Advances, plus accrued interest thereon, in 24 equal monthly installments commencing on January 31, 2023 and continuing thereafter on the last day of each month (or, if such last day is not a Business Day, on the Business Day immediately preceding such last day. Interest on the unpaid Advances will accrue from the date of each Advance at a rate equal to fifteen percent (15%) per annum. Interest will be calculated on the basis of 365 days in a year.” The amendment raised the maximum amount of the Credit Facility to $6,000,000. In addition, the interest which is accrued monthly between July 1, 2022, and December 31, 2022, will be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08 per share of common stock in the amount of the interest accrued for each month.

 

On January 31, 2023, the Company then entered into Amendment No. 1 (the “Amendment”), which amends our existing Credit Facility Agreement[1], dated as of November 11, 2022, between the Company and Thomas B. Akin, and any convertible notes issued thereunder. The Amendment amends the existing Credit Facility Agreement to extend the maturity of the agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the agreement is to be paid quarterly in shares of our common stock, at a price per share equal to the volume-weighted average price of our common stock quoted on the Over-The Counter Venture Market operated by OTC Markets Group Inc. (“OTCQB®”) over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible notes to be issued under the Credit Agreement in the future and any outstanding convertible notes issued under the existing Credit Facility Agreement. The Amendment was considered a debt modification as the cash flows under the amended terms do not differ by at least 10% from the cash flows under the original agreement.

 

On August 22, 2023, The Company took a draw of an additional $150,000 under the Credit Agreement.

 

On September 20, 2023, The Company took a draw of an additional $250,000 under the Credit Agreement.

 

During the nine months ended September 30, 2023, a total of $591,880 of interest was accrued by the company. Interest payable of $391,139 to Thomas Akin was then surrendered to be converted and exchanged for the issuance of 362,335 shares of restricted common stock. The company recorded a loss of settlement of interest payable of $10,315 and amortized discount expense of $89,349.

 

During the nine months period ending September 30, 2023, the Company issued warrants to purchase an aggregate of 121,808 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under the Credit Agreement. The estimated aggregate fair value of the warrants issued is $28,463 using the Black-Scholes option valuation model as of September 30, 2023.

 

As of September 30, 2023, the Company had drawn a total of $5,573,125 and we have accrued interest of $589,345 and a discount balance of $191,653.

 

Unsecured Promissory Note

 

On July 1, 2021, we entered into UP Notes in the aggregate principal amount of $271,875 with Talkot Fund, LP and investor in the Company. Each UP Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest are due and payable no later than December 31, 2023. We may prepay any of the UP Notes without notice, subject to a two percent (2%) pre-payment penalty. The UP Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued to Talkot Fund LP warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this UP Note.

 

On January 31, 2023, the Lender agreed to postpone the 24-month repayment period to a later period commencing on January 31, 2024, and further agreed that interest accrued on the loan between July 1, 2022 and December 1, 2025 is to be settled in shares of the Company’s common stock quarterly.

 

During the nine months ended September 30, 2023, a total of $30,926 of interest was accrued by the company. Interest of $20,504 payable to Talkot Fund, LP was then surrendered to be converted and exchanged for the issuance of 18,987 shares of restricted common stock. The company recorded a loss of settlement of interest payable of $542.

 

As of September 30, 2023, the Company had an outstanding principal balance of $271,875, accrued interest of $65,952.

 

Interest Expense

 

Interest expense was $237,376 and $193,501 during the three months ended September 30, 2023 and 2022, respectively.

 

Interest expense was $720,265 and $520,454 during the nine months ended September 30, 2023 and 2022, respectively.

 

11
Table of Contents 

 

8. Stockholders’ Equity

 

Common Stock and Equity Payable

 

2022

 

On February 9, 2022, 17 warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $0.80 per share, resulting in additional capital of $2,550,552. As an inducement for the holders’ exercise of the warrants, we issued the holders 3,188,190 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in February 2025. We have recorded an additional stock-based expense of $382,048.

 

On June 29, 2022, the Company received private investment funds to purchase 1,062,500 shares of its common stock at a price of $0.80 per share, resulting in additional capital of $850,000, and issued the holders 1,062,500 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in June 2025.

 

On August 24, 2022, the Company received private investment funds to purchase 1,500,000 shares of its common stock at a price of $0.80 per share, resulting in additional capital of $1,200,000, and issued the holders 1,500,000 new warrants to purchase common stock at $1.50 per share over a three year period expiring in August 2025.

 

During the nine months ended September 30, 2022 a total of $161,750 of interest was converted into 149,770 shares of Common Stock.

 

2023

 

On January 31, 2023 a total of 545,012 shares were issued to John Harris, a former director. The shares were issued based on the total Restricted Stock Units earned by Mr. Harris as director compensation that were fully vested as of March 29, 2022. Restricted stock expense is recorded on the date it vests and no expense was recognized during the three months ended March 31, 2023.

 

On March 27, 2023 a total of 154,106 shares of common stock were granted from equity payable to Thomas Akin as settlement of $166,432 of interest payable. The Company recorded a loss on settlement of interest payable of $44,325 on December 31, 2022.

 

On March 27, 2023 a total of 9,651 shares of common stock were granted from equity payable to Talkot Fund LP as settlement of $10,423 of interest payable. The Company recorded a loss on settlement of interest payable of $2,757 on December 31, 2022.

 

On March 31, 2023 a total of $195,171 of interest was accrued and settled to equity payable for the issuance of 180,715 shares of common stock. The company recorded a loss of settlement of interest payable of $10,315.

 

On March 31, 2023 a total of $10,196 of interest was accrued and settled to equity payable for the issuance of 9,441 shares of common stock. The company recorded a loss of settlement of interest payable of $542.

 

During March, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,587,487. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 1,792,745 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in February 2025. The Company recorded $577,000 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

 

On June 30, 2023 a total of $196,148 of interest was accrued and settled to equity payable for the issuance of 181,620 shares of common stock.

 

On June 30, 2023 a total of $10,309 of interest was accrued and settled to equity payable for the issuance of 9,546 shares of common stock.

 

During August and September of 2023, 18 warrant holders exercised their common stock purchase warrant for 1,960,976 shares at the exercise price of $.82 per share, resulting in additional capital of $1,608,000. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 3,921,952 new warrants to purchase common stock at $.82 per share over a one and three-year period expiring between August and September 2026. The Company recorded $1,146,562 of stock-based expense related to warrants issued during the warrant conversion offer on September 6, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on an average volatility rate of 63% and 73% and an option fair value of between $0.21 and $0.40.

 

During the nine months ended September 30, 2023 a total of 553,279 shares were issued from stock payable related to related party accrued interest.

 

As of the nine months ended September 30, 2023 we had an equity payable balance of $100,862.

 

12
Table of Contents 

 

Stock-based Plans

 

Stock Option Activity

 

The following table summarizes stock option activity for the nine months ended September 30, 2023.

 

   Options 
Outstanding at December 31, 2021   6,246,466 
Granted   1,375,000 
Exercised    

Forfeited/canceled 

   (330,623)
Expired   (599,627)
Outstanding at December 31, 2022   6,691,216 
Granted   2,645,000 
Exercised    
Forfeited/canceled   (79,165)
Expired   (1,340,384)
Outstanding at September 30, 2023   7,916,667 

 

2022

 

On March 29, 2022, the Company granted one employee 150,000 options to purchase shares of the Company’s common stock at the closing price as of March 29, 2022, of $0.8289 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until March 29, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 72.33% and an option fair value of $0.54 was $81,035.

 

On May 16, 2022, the Company granted three employees 45,000 options to purchase shares of the Company’s common stock at the closing price as of May 16, 2022, of $0.97 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until May 16, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.45% and an option fair value of $0.642608 was $28,917.

 

On September 22, 2022, the Company granted one employee 1,000,000 options to purchase shares of the Company’s common stock at the closing price as of September 2022, of $0.98 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until September 29, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 76.15% and an option fair value of $0.697499 was $697,499.

 

2023

 

On May 11, 2023 the Company granted three employees 295,000 options to purchase shares of the Company’s common stock at the closing price as of May 11, 2023 of $0.98 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until May 16, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 75.76% and an option fair value of $0.705183 was $208,029.

 

On July 14, 2023 the Company granted one employees 1,000,000 options to purchase shares of the Company’s common stock at the closing price as of July 14, 2023 of $0.85 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until July 14, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.55% and an option fair value of $0.5590 was $605,383.

 

On July 17, 2023 the Company granted one employees 700,000 options to purchase shares of the Company’s common stock at the closing price as of July 17, 2023 of $0.79 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until July 17, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.57% and an option fair value of $0.5713 was $396,441.

 

On August 25, 2023 he Company granted four employees 650,000 options to purchase shares of the Company’s common stock at the closing price as of August 25, 2023 of $0.65 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until August 25, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 64.81% and an option fair value of $0.4257 was $285,773.

 

13
Table of Contents 

 

Stock-Based Compensation Expense from Stock Options and Warrants

 

The impact on our results of operations of recording stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 were as follows:

 

   2023   2022   2023   2022 
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
General and administrative  $62,599   $65,800   $181,382   $571,462 
Sales and marketing   108,348    20,972    248,790    56,183 
Engineering, research, and development   46,830    41,185    119,334    171,734 
Total  $217,777   $127,957   $549,506   $799,379 

 

Valuation Assumptions

 

The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the nine months ended September 30, 2023 and 2022.

 

   Nine Months Ended 
   September 30, 
   2023   2022 
Risk-free interest rate   3.99%   2.47%
Expected life (years)   7.50    5.90 
Expected dividend yield   %   %
Expected volatility   73.47%   69.23%

 

The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options.

 

The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on the historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of the Company’s stock-based awards.

 

The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts.

 

The expected volatility in 2023 and 2022 is based on the historical publicly traded price of our common stock.

 

Restricted stock units

 

The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2022 and for the nine months ended September 30, 2023:

 

   Shares 
Outstanding at December 31, 2021   1,685,141 
Awarded   244,792 
Released    
Canceled/forfeited/expired    
Outstanding at December 31, 2022   1,929,933 
Awarded   243,048 
Released   (545,012)
Canceled/forfeited/expired    
Outstanding at September 30, 2023   1,627,969 
      
Expected to vest at September 30, 2023   1,627,969 
Vested at September 30, 2023   1,526,405 
Unvested at September 30, 2023    
Unrecognized expense at September 30, 2023  $ 

 

14
Table of Contents 

 

2022

 

On March 29, 2022, the company granted four independent directors a total of 78,420 restricted stock units. The units were valued at $65,002 or $0.829 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

On May 16, 2022, the company granted four independent directors a total of 54,168 restricted stock units. The units were valued at $65,002 or $1.20 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

On September 30, 2022, the company granted four independent directors a total of 65,100 restricted stock units. The units were valued at $65,002 or $0.9985 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

During the nine months ended September 30, 2022, the Company recorded $195,005 in restricted stock expense as board compensation.

 

2023

 

On March 31, 2023, the company grated granted four independent directors a total of 61,342 restricted stock units. The units were valued at $65,002 or $1.05 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) March 31, 2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

On June 30, 2023, the company granted four independent directors a total of 80,160 restricted stock units. The units were valued at $65,003 or $0.81 per share, based on the closing stock price on the date of the grant. All units vest immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) June 30, 2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

On September 30, 2023, the company granted four independent directors a total of 101,564 restricted stock units. The units were valued at $65,001 or $0.64 per share, based on the closing stock price on the date of the grant. All units vest immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) September 30,2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

In the nine months ended September 30, 2023, the Company recorded $195,006 in restricted stock expense as board compensation.

 

Stock Based Compensation from Restricted Stock

 

The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and nine months ended September 30, 2023 and 2022 was as follows:

 

   2023   2022   2023   2022 
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
General and administrative  $65,001   $65,002   $195,006   $195,005 
Sales and marketing  $   $   $   $ 
Total  $65,001   $65,002   $195,006   $195,005 

 

As of September 30, 2023, there was no unearned restricted stock unit compensation.

 

Warrants

 

The following table summarizes investor warrants as of September 30, 2023 and the years ended December 31, 2022 and 2021:

 

   Shares   Weighted Average Exercise Price   Weighted
Average
Remaining
Contractual
Term (Years)
 
Outstanding at December 31, 2021   3,246,690   $2.26    3.59 
Granted   6,089,398   $     
Exercised   (3,188,190)  $     
Canceled/forfeited/expired      $     
Outstanding at December 31, 2022   6,147,898   $1.45    2.27 
Granted   5,715,697   $     
Exercised   (5,548,463)  $     
Canceled/forfeited/expired      $     
Outstanding at September 30, 2023   6,315,132   $1.62    2.50 

 

15
Table of Contents 

 

2022

 

On February 9, 2022, 17 warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $0.80 per share, resulting in additional capital of $2,550,553. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 3,188,190 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in February 2025. The Company recorded $382,048 of stock-based expense related to warrants issued during the warrant conversion offer on February 9, 2022.

 

On June 29, 2022, six private investors purchased 1,062,500 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in June 2025, and 1,062,500 shares at the exercise price of $0.80 per share, resulting in additional capital of $850,000.

 

On August 24, 2022, five private investors purchased 1,500,000 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in August 2025, and 1,500,000 shares at the exercise price of $0.80 per share, resulting in additional capital of $1,200,000.

 

2023

 

During March 2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 3,921,952 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in February 2025. The Company recorded $577,000 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

 

During August and September of 2023, 18 warrant holders exercised their common stock purchase warrant for 1,906,976 shares at the exercise price of $.82 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 1,793,745 new warrants to purchase common stock at $.82 per share over a three-year period expiring between August and September 2026. The Company recorded $1,146,047 of stock-based expense related to warrants issued during the warrant conversion offer on September 6, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on an average volatility rate of 72% and an option fair value of $0.2922.

 

9. Fair Value Measurements

 

Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure certain financial assets and liabilities at fair value.

 

The following table presents assets that are measured and recognized at fair value as of September 30, 2023 on a recurring and non-recurring basis:

 

Description  Level 1   Level 2   Level 3   Gains (Losses) 
Goodwill (non-recurring)  $   $   $   $ 
Intangibles, net (non-recurring)  $   $   $78,244   $ 

 

The following table presents assets that are measured and recognized at fair value as of December 31, 2022 on a recurring and non-recurring basis:

 

Description  Level 1   Level 2   Level 3   Gains (Losses) 
Goodwill (non-recurring)  $   $   $   $ 
Intangibles, net (non-recurring)  $   $   $194,772   $ 

 

10. Commitments and Contingencies

 

Litigation

 

The company had a pending legal proceeding related to a Telephone Consumer Protection Act (“TCPA”) violation. This is a putative class action complaint alleging that the defendant initiated telephone solicitations through text messages in violation of the Florida Telephone Solicitation Act, Fla. Stat. §501.059 (“FTSA”). The defense of the matter was tendered to the Company by its client, Sonic Industries, Inc. During the nine months ended September 30, 2023, the Company has settled five TCPA claims for a total settlement loss of $25,500 and this amount is included within settlement losses on the accompanying unaudited consolidated statements of operations and comprehensive loss.

 

Operating Lease

 

As described in Note 6, the Company has a lease agreement for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $25,953 to $28,733. The first 12 months of the lease included a 50% abatement period. As of September 30, 2023, we have an operating lease asset balance for this lease of $825,041 and an operating lease liability balance for this lease of $1,001,579 recorded in accordance with ASC 842.

 

16
Table of Contents 

 

11. Related Party Transactions

 

Secured Promissory Notes

 

On June 30, 2021, we entered into a Credit Facility Agreement with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Facility Agreement was amended on November 11, 2022 to allow the Company to borrow up to $6,000,000. The Credit Facility Agreement was amended again on January 31, 2023 to extend the maturity of the agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025.

 

Unsecured Promissory Note

 

On July 1, 2021, we entered into UP Notes in the aggregate principal amount of $271,875 with Talkot Fund, LP and investor in the Company. Each UP Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest are due and payable no later than December 31, 2023.

 

For more details regarding the two related party transactions, please refer to Note 7 - Notes Payable and Interest Expense.

 

Related Party Warrant Exercise

 

On March 2, 2023, Thomas Akin exercised his common stock purchase warrant for 749,987 shares at the exercise price of $1.00 per share, resulting in additional capital of $749,987. As an inducement for the holder’s exercise of the warrants, we issued the holder 374,994 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in March 2026. The Company recorded $120,598 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

 

On February 7, 2023, Talkot Fund LP exercised their common stock purchase warrant for 750,000 shares at the exercise price of $1.00 per share, resulting in additional capital of $750,000. As an inducement for the holder’s exercise of the warrants, we issued the holder 375,000 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in March 2026. The Company recorded $120,600 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

 

On August 7, 2023, Thomas Akin exercised his common stock purchase warrant for 426,830 shares at the exercise price of $.82 per share, resulting in additional capital of $350,000. As an inducement for the holder’s exercise of the warrants, we issued the holder 853,660 new warrants to purchase common stock at $.82 per share over a three-year period expiring in March 2026. The Company recorded $178,136 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 64% and an option fair value of $0.2087.

 

On August 7, 2023, Talkot Fund LP exercised their common stock purchase warrant for 426,830 shares at the exercise price of $.82 per share, resulting in additional capital of $350,000. As an inducement for the holder’s exercise of the warrants, we issued the holder 853,660 new warrants to purchase common stock at $.82 per share over a three-year period expiring in March 2026. The Company recorded $178,136 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 64% and an option fair value of $0.2087.

 

12. Subsequent Events

 

The Company has discontinued the sale and operation of the Belly loyalty card platform. The last date of operation was October 15, 2023.

 

On November 10, 2023 three shareholders purchased convertible notes from the Company in the amount of $400,000. The Convertible Note accrues interest monthly at 8% per annum. Principal and accrued interest payments are due in full on November 8, 2026 under the Convertible Note. The Convertible Note and all accrued interest thereon are convertible into shares of our common stock, from time to time, at the option of the holder thereof, at a conversion price per share equal to the larger of either $0.50 or of the volume-weighted average price of our common stock quoted on the OTCQB ® Venture Market operated by OTC Markets Group Inc. over the thirty (30) trading days immediately preceding such date (the “Conversion Price”). For value received the shareholders received 666,668 warrants to purchase common shares at and exercise price of $0.60 per share over a three year period ending November 10, 2026.

 

17
Table of Contents 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This Quarterly Report on Form 10-Q contains forward-looking statementsas defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in connection with the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially and adversely from those expressed or implied by such forward-looking statements Such forward-looking statements include statements about our expectations, beliefs or intentions regarding our potential product offerings, business, financial condition, results of operations, strategies or prospects. You can identify forward-looking statements by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends, or results as of the date they are made and are often identified by the use of words such as anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,or will,and similar expressions or variations. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those risks disclosed under the caption Risk Factorsincluded in our 2020 annual report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on March 30, 2021, and in our subsequent filings with the SEC. Furthermore, such forward-looking statements speak only as of the date of this report. We undertake no obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

 

Overview

 

Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized data-driven marketing campaigns.

 

Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to:

 

  Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence.
  Measure, predict, and boost guest frequency and spend by channel.
  Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion, and media program.
  Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions, and Integrated Loyalty programs.

 

Mobivity’s Recurrency, delivered as a Software-as-a-Service (“SaaS”) platform, is used by leading brands including Subway, Sonic Drive-In, Baskin Robbins, Chick-fil-A and Checkers/Rally’s across more than 40,000 retail locations globally.

 

We’re living in a data-driven economy. By 2003 — when the concept of “Big Data” became common vernacular in marketing - the amount of data being created every two days was equal to the amount created in all of the time prior to 2003. Today, 90% of the world’s data has been created in just the past two years. Unfortunately, despite there being so much data accumulated, only one percent of data is being utilized today by most businesses.

 

The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems, and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. This is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks, and Yum Brands.

 

Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media, and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental revenue from their customers.

 

The Recurrency Platform

 

Mobivity’s Recurrency™ platform unlocks valuable POS and mobile data to help transform customer transactions into actionable and attributable marketing insights. Our technology provides transactional data, in real-time, that uncovers market-basket information and attributes both online and traditional promotions. Recurrency is comprised of seven components, described in detail below.

 

POS Data Capture

 

Recurrency captures, normalizes, integrates, and stores transaction data and is compatible with most POS systems used by restaurants and retailers today. The result is a clean useful dataset upon which to predict and influence customers’ buying behavior and deliver basket-level insights.

 

Analytics Powered by Machine Learning

 

Recurrency uses Machine Learning (“ML”) to uncover patterns in the buying behaviors of consumers and leverages that data to suggest pricing optimizations, and guide marketing campaigns.

 

Offers and Promotions

 

Recurrency provides a digital wallet system for creating and managing dynamic offers and promotions, enabling accurate and complete closed-loop attribution across all channels, media, and marketing efforts. Retailers can deploy one-time, limited-use, and multi-use promotions across all online and offline marketing channels that are scannable at the POS or redeemable online, enabling fraud-free, controllable promotion delivery and attribution at scale. Marketing teams can use the comprehensive attribution analysis and insights to optimize media mix and spend for maximum Return on Marketing Spend (“ROMS”).

 

18
Table of Contents 

 

Predictive Offers

 

Recurrency leverages the normalized data captured at the POS and applies Artificial Intelligence (“AI”) to build profiles of both known and anonymous customers, analyzes pre and post-redemption behavior, and then predicts offers that will drive the highest increases in customer spend and frequency at the lowest discount possible. The result is optimized, personalized promotions that produce the highest ROMS possible.

 

Personalized Receipt Promotions

 

Recurrency unlocks the power of transactional data to create relevant and timely customer messages printed on the receipts already being generated at the POS. Both clients and agencies are using Recurrency to drive better results and make decisions around offers, promotions, and customer engagement through the medium of the printed receipt. Software integrated with leading POS systems, such as Oracle or MICROS, or installed directly onto receipt printer platforms, such as Epson’s OmniLink product, dynamically controls what is printed on receipts including images, coupons, announcements, or other calls-to-action, such as invitations to participate in a survey. Recurrency offers a Web-based interface where users can design receipt content and implement business rules to dictate what receipt content is printed in particular situations. All receipt content is transmitted to cloud-based Recurrency for storage and analysis.

 

Customized Mobile Messaging

 

Recurrency transforms standard short message service (“SMS”), multimedia messaging service (“MMS”), and rich communication services (“RCS”) into a data-driven marketing medium. Recurrency tracks and measures offer effectiveness at a more granular level than other solutions, allowing clients to create smarter offers and drive higher redemption rates. Our proprietary platform connects to all wireless carriers so that any consumer, on any wireless service (for example, Verizon), can join our customer’s SMS/MMS mobile marketing campaign. Our customers use Recurrency’s self-service interface to build, segment, target and optimize mobile messaging campaigns to drive increased guest frequency and spend. Recurrency is an industry leader in RCS messaging and has an industry-leading broadcast reach.

 

Belly Loyalty

 

Mobivity’s Belly Loyalty solution drives increased customer engagement and frequency with a customer-facing digital rewards platform via an app and digital pad. Using Belly, customers can customize rewards and leverage pre-built email campaigns and triggers to encourage greater frequency as well as to identify and reactivate lapsed customers.

 

Company Strategy

 

Our objective is to build an industry-leading SaaS product that connects consumers to merchants and brands. The key elements of our strategy are:

 

Exploit the competitive advantages and operating leverage of our technology platform. The core of our business is our proprietary POS Data Capture technology. Several years of development went into designing POS Data Capture such that the process of intercepting POS data and performing actions, such as controlling the receipt printer with receipt is scalable, portable to a wide variety of POS platforms, and does not impact performance factors including the print speed of a typical receipt printer. Furthermore, we believe the transmission of POS data to Mobivity’s cloud-based data stores presents a very competitive and innovative method of enabling POS data access. Additionally, we believe that our Recurrency platform is more advanced than technologies offered by our competitors and provides us with a significant competitive advantage. With more than ten years of development, we believe that our platform operates SMS/MMS text messaging transactions at a “least cost” relative to competitors while also being capable of supporting the SMS/MMS text messaging transactional volume necessary to serve our goal of several thousand end users. Leveraging our Recurrency platform allows for full attribution of SMS/MMS offers, which we believe is a unique combination of both SMS/MMS text messaging and POS data.
  Evolve our sales and customer support infrastructure to uniquely serve very large customer implementations such as franchise-based brands that operate a large number of locations. Over the past few years, we have focused our efforts on the development of our technology and solutions with the goal of selling and supporting small and medium-sized businesses. Going forward, we intend to significantly increase our investments in sales and customer support resources tailored to selling to customers that operate franchise brands. Today we support more than 30,000 merchant locations globally.
  Acquire complementary businesses and technologies. We will continue to search and identify unique opportunities which we believe will enhance our product features and functionality, revenue goals, and technology. We intend to target companies with some or all of the following characteristics: (1) an established revenue base; (2) strong pipeline and growth prospects; (3) break-even or positive cash flow; (4) opportunities for substantial expense reductions through integration into our platform; (5) strong sales teams; and (6) technology and services that further build out and differentiate our platform. Our acquisitions have historically been consummated through the issuance of a combination of our common stock and cash.
  Build our intellectual property portfolio. We currently have nine issued patents that we believe have significant potential applications in the technology industry. We plan to continue our investment in building a strong intellectual property portfolio.

 

While these are the key elements of our current strategy, there can be no guarantees that our strategy will not change or that our strategy will be successful.

 

Recent Events

 

2023 Warrants Exercises

 

During the quarter ended March 30, 2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders 1,793,745 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in February 2025.

 

During the quarter ended September 30, 2023, 18 warrant holders exercised their common stock purchase warrant for 1,906,976 shares at the exercise price of $.82 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 1,793,745 new warrants to purchase common stock at $.82 per share over a three-year period expiring between August and September 2026. The Company recorded $1,146,047 of stock-based expense related to warrants issued during the warrant conversion offer on September 6, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on an average volatility rate of 72% and an option fair value of $0.2922.

 

19
Table of Contents 

 

2023 Related Party Notes Payable

 

On January 31, 2023, the Company entered into Amendment No. 1 (the “Amendment”) to the Amended and Restated Credit Facility Agreement and Convertible Notes which amends our existing Amended and Restated Credit Facility Agreement, dated as of November 11, 2022, between the Company and Thomas B. Akin, a director of the Company (the “Existing Credit Agreement” and as amended by the Amendment, the “Credit Agreement”) and any convertible notes issued thereunder. The Amendment amends the Existing Credit Agreement to extend the maturity of the Credit Agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the Credit Agreement is to be paid quarterly in shares of our common stock, at a price per share equal to the volume-weighted average price of our common stock quoted on the OTCQB® Venture Market operated by OTC Markets Group Inc. over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible note to be issued under the Credit Agreement in the future and any outstanding convertible notes issued under the Existing Credit Agreement.

 

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, a copy of which was filed with the SEC on the Company’s Current Report on Form 8-Kdated January 31, 2023, and is attached as Exhibit 10.1 to such Current Report on Form 8-K and incorporated herein by reference.

 

2023 Shares Issued

 

On January 31, 2023 a total of 545,012 shares were issued to John Harris, a former director. The shares were issued based on the total Restricted Stock Units earned by Mr. Harris as director compensation.

 

On March 27, 2023 a total of 154,106 shares of common stock were issued to Thomas Akin as settlement of interest payable.

 

On March 27, 2023 a total of 9,651 shares were issued to Talkot Fund LP as settlement of interest payable.

 

On May 08,2023 a total of 180,715 shares of common stock were issued to Thomas Akin as settlement of interest payable.

 

On May 08, 2023 a total of 9,441 shares were issued to Talkot Fund LP as settlement of interest payable.

 

On July 17,2023 a total of 181,620 shares of common stock were issued to Thomas Akin as settlement of interest payable.

 

On July 17, 2023 a total of 9,546 shares were issued to Talkot Fund LP as settlement of interest payable.

 

Results of Operations

 

Revenues

 

Revenues consist primarily of those generated by a suite of products under the Recurrency platform. The Recurrency platform is comprised of POS Data Capture, Analytics, Offers and Promotions, Predictive Offers, Personalized Receipt Promotions, Customized Mobile Messaging, Belly Loyalty, and other revenues.

 

Revenues for the three months ended September 30, 2023, were $1,633,071 a decrease of $257,366 compared to the same period in 2022.

 

Revenues for the nine months ended September 30, 2023, were $5,375,724 a decrease of $411,444 or 7% compared to the same period in 2022

 

This decrease is primarily due to a decrease of in subscription revenue.

 

Cost of Revenues

 

Cost of revenues consists primarily of cloud-based software licensing fees, short code maintenance expenses, messaging-related expenses, and other expenses.

 

Cost of revenues for the three months ended September 30, 2023, was $1,160,880, a decrease of $645,142, or 36%, compared to $1,806,022 for the same period in 2022.

 

Cost of revenues for the nine months ended September 30, 2023, was $3,598,661, a decrease of $585,058, or 14%, compared to $4,183,719 for the same period in 2022.

 

This increase is primarily due to an decrease of $500,000 in application expense.

 

General and Administrative

 

General and administrative expenses consist primarily of salaries and personnel-related expenses, consulting costs, and other expenses.

 

General and administrative expenses increased $1,309,195 or 133% to $2,292,623, during the three months ended September 30, 2023, compared to $983,428 for the same period in 2022. The increase in general and administrative expenses was primarily due to an increase in stock related expense for the warrant exercise that occurred during the period.

 

General and administrative expenses increased $1,819,294 or 59% to $4,907,882 during the nine months ended September 30, 2023, compared to $3,088,588 for the same period in 2022. The increase in general and administrative expenses was primarily due to an increase in stock related expense for the warrant exercise that occurred during the period.

 

Sales and Marketing

 

Sales and marketing expenses consist primarily of salaries and personnel-related expenses, stock-based compensation expenses, consulting costs, and other expenses.

 

Sales and marketing expenses increased $93,798, or 15%, to $708,398 during the three months ended September 30, 2023, compared to $614,600 for the same period in 2022. The increase is primarily due to and $112,000 increase in payroll expense.

 

Sales and marketing expenses increased $224,158, or 13%, to $2,002,529 during the nine months ended September 30, 2023, compared to $1,778,371 for the same period in 2022. The increase is primarily due to a $297,000 increase in payroll.

 

20
Table of Contents 

 

Engineering, Research & Development

 

Engineering, research & development costs include salaries, stock-based compensation expenses, travel, consulting costs, and other expenses.

 

Engineering, research & development expenses increased $183,742, or 23%, to $968,546 during the three months ended September 30, 2023, compared to $784,804 for the same period in 2022. This decrease is primarily due to an decrease of $62,000 in payroll expense.

 

Engineering, research & development expenses increased $146,401, or 6%, to $2,507,264 during the nine months ended September 30, 2023, compared to $2,360,863 for the same period in 2022. This decrease is primarily due to a $238,000 decrease in payroll expenses.

 

Depreciation and Amortization

 

Depreciation and amortization expenses consist of depreciation on our equipment and amortization of our intangible assets.

 

Depreciation and amortization expense decreased $87,899 or 74%, to $30,418 during the three months ended September 30, 2023 compared to $118,317 for the same period in 2022.This decrease is primarily due to decrease in intangible assets due to impairment at the end of 2022.

 

Depreciation and amortization expenses decreased $222,148 or 63%, to $130,902 during the nine months ended September 30, 2023 compared to $353,050 for the same period in 2022. This decrease is primarily due to decrease in intangible assets due to impairment at the end of 2022.

 

Impairment of Intangible Assets

 

Impairment of intangible asset expenses decreased to $0 during the three months ended September 30, 2023 compared to $238,143 for the same period in 2022.

 

Impairment of intangible asset expenses decreased to $0 during the nine months ended September 30, 2023 compared to $238,143 for the same period in 2022.

 

Interest Expense

 

Interest expense increased $43,875, or 23%, to $237,376 during the three months ended September 30, 2023, compared to $193,501 in the same period in 2022. This increase in interest expense is primarily related to the increased balance on related party notes payable.

 

Interest expense increased $199,811 or 38%, to $720,265 during the nine months ended September 30, 2023, compared to $520,454 in the same period in 2022. This increase in interest expense is primarily related to the increase balance on related party notes payable.

 

Settlement Losses

 

Settlement losses consist of legal settlement for TCPA settlements.

 

Settlement losses for the three and nine months ended September 30, 2023 were $13,000 and $25,500, respectively. There were no settlement losses for the three and nine months ended September 30, 2022.

 

Loss on Settlement of Debt

 

Loss on Settlement of debt consists of the expense from the settlement of notes payable when they are settled into shares.

 

Loss on settlement of debt for the three and nine months ended September 30, 2023 was $0 and $10,857, respectively. There was no loss on settlement of debt for the three and nine months ended September 30, 2022.

 

Foreign Currency

 

The Company’s financial results are impacted by volatility in the Canadian/U.S. Dollar exchange rate. The average U.S. Dollar exchange rate for the three and nine months ended September 30, 2023, was $1 Canadian equals $0.75 and $0.74 U.S. Dollars, respectively. This compares to an average rate of $1 Canadian equals $0.77 and $0.78 during the same period in 2022. The Company’s functional or measurement currency is the U.S. Dollar. Based on a U.S. Dollar functional currency, the following are the key areas impacted by foreign currency volatility:

 

  The Company sells products primarily in U.S. Dollars; therefore, reported revenues are not highly impacted by foreign currency volatility.
  A portion of the Company’s expenses are incurred in Canadian Dollars and therefore fluctuate in U.S. Dollars as the U.S. Dollar varies. A weaker U.S. Dollar results in an increase in translated expenses, and a stronger U.S. Dollar results in a decrease.
  Changes in foreign currency rates also impact the translated value of the Company’s working capital that is held in Canadian Dollars. Foreign exchange rate fluctuations result in foreign exchange gains or losses based upon movement in the translated value of Canadian working capital into U.S. Dollars.

 

The change in foreign currency was a gain of $91,825 and a loss of $76,228 for the three months ended September 30, 2023 and 2022, respectively.

 

The change in foreign currency was a gain of $123,190 and a loss of $76,862 for the nine months ended September 30, 2023 and 2022, respectively.

 

Liquidity and Capital Resources

 

As of September 30, 2023, we had current assets of $1,073,338, including $457,934 in cash, and current liabilities of $6,967,713, resulting in a working capital deficit of $5,894,375.

 

We believe as of the date of this report, we do not have the working capital on hand, along with our expected cash flow from operations and budget reductions, to sufficiently fund our current level of operations through the end of the next 12 months or beyond. We will require additional capital and will seek to obtain additional working capital through the sale of our securities and, if available, bank lines of credit. There can be no assurance we will be able to obtain access to capital as and when needed, or that the terms of any available financing will be commercially reasonable.

 

21
Table of Contents 

 

Cash Flows

 

   Nine Months Ended 
   September 30, 
   2023   2022 
Net cash provided by (used in):          
Operating activities  $(5,644,980)  $(4,966,359)
Investing activities   (24,552)   (30,742)
Financing activities   5,575,483    5,371,407 
Effect of foreign currency translation on cash flow   125,243    (92,985)
Net change in cash  $31,194   $281,321 

 

Operating Activities

 

We used cash in operating activities totaling $5,644,980 during the nine months ended September 30, 2023 and used cash in operating activities totaling $4,966,359 during the nine months ended September 30, 2022. Key drivers of the cash used in operating activities are the net loss of $8,528,529 and changes to accounts receivable of $683,060, accrued interest of $621,806, accrued and deferred personnel compensation of $457,687, and deferred revenue and customer deposits of $684,175.

 

Investing Activities

 

Investing activities during the nine months ended September 30, 2023, consisted of $6,300 in patent fees compared to $0 in the nine months ending September 2022 and $18,252 of equipment purchases compared to $18,712 in the nine months ended September 30, 2022. In addition, there was $0 in capitalized software development costs in nine months ended September 30, 2023 compared to $12,030 in the nine months ended September 30, 2022

 

Financing Activities

 

Financing activities during the nine months ended September 30, 2023, consisted of $5,195,487 additional paid-in capital from a warrant conversion to common stock, compared to $2,550,552 additional paid in capital from a warrant conversation to common stock and $2,050,000 additional paid-in capital from a PIPE funding in the nine months ended September 30, 2022.In addition there was $400,000 proceeds for related party notes payable compared to $800,000 in the same period in 2022, and $20,004 in payment on notes payable compared to $29,145 in the same period in 2022.

 

Critical Accounting Policies and Estimates

 

Refer to Note 2, “Summary of Significant Accounting Policies,” in the accompanying notes to the condensed consolidated financial statements for a discussion of recent accounting pronouncements.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

We are a smaller reporting company as defined by Item 10(f)(1) of Regulation S-K. As such, we are not required to provide the information set forth in this item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

As required by Rule 13a-15(b) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. “Disclosure controls and procedures,” as defined in Exchange Act Rule 13a-15(e), are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, , including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that as of September 30, 2023 our disclosure controls and procedures were not effective.

 

As a small company with limited resources that are mainly focused on the development and sales of software products and services, the Company does not employ a sufficient number of staff in its finance department to possess an optimal segregation of duties or to provide optimal levels of oversight. This has resulted in certain audit adjustments and management believes that there may be a possibility for a material misstatement to occur in future periods while it employs the current number of personnel in its finance department.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, that occurred during the nine months ended September 30, 2023 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 

22
Table of Contents 

 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

The Company had a legal proceeding related to TCPA (Telephone Consumer Protection Act) Violation. This is a putative class action complaint alleging that Defendant initiated telephone solicitations through text messages in violation of the Florida Telephone Solicitation Act, Fla. Stat. §501.059 (“FTSA”). The defense of the matter was tendered to the Company by its client, Sonic Industries, Inc. During the nine months ended September 30, 2023, the Company has settled four TCPA claims for a total settlement loss of $25,500 and this amount is included within settlement losses on the accompanying unaudited consolidated statements of operations and comprehensive loss.

 

Item 1A. Risk Factors.

 

We are a smaller reporting company, as defined by Item 10(f)(1) of Regulation S-K. As such, we are not required to provide the information set forth in this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the March 2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders 1,793,745 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in March 2026.

 

During August 2023, 18 warrant holders exercised their common stock purchase warrant for 1,906,976 shares at the exercise price of $.82 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 1,793,745 new warrants to purchase common stock at $.82 per share over a three-year period expiring between August and September 2026.

 

For the foregoing warrants, the exercise price of the warrant and the number of the shares issuable upon exercise of the warrant are subject to customary adjustments prior to exercise upon the occurrence of certain events affecting all outstanding shares of common stock.

 

The foregoing securities were issued in reliance on an exemption from registration set forth in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) to a limited number of persons who were “accredited investors,” as defined in Rule 501 of Regulation D of the Securities Act, without the use of any general solicitations or advertising to market or otherwise offer the securities for sale. None of the shares, warrants or shares of common stock issued upon exercise of the warrants have been registered under the Securities Act or applicable state securities laws and none may be offered or sold in the United States absent registration under the Securities Act, or an exemption from such registration requirements. Neither this quarterly report on Form 10-Q nor any exhibit attached hereto shall constitute an offer to sell or the solicitation of an offer to buy any securities.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information

 

The information set forth below is included herein for purposes of providing the disclosure required under “Item 1.01 Entry Into a Material Definitive Agreement; Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. “ of Form 8-K.

 

On November 13, 2022, the Company entered into an amended and restated credit facility agreement with Thomas B. Akin, a director of the Company (the “A&R Credit Agreement”) and a corresponding convertible note in the amount of $4,466,043 (the “Convertible Note”). The A&R Credit Agreement amends and restates the current Credit Agreement and allows for the Company to borrow up to $6 million in advances. The Convertible Note accrues interest monthly at 15% per annum. Principal and accrued interest payments are due in 24 monthly installments under the Convertible Note beginning on January 31, 2023 and continuing on the last day of each of the next 23 months thereafter. The Convertible Note and all accrued interest thereon are convertible into shares of our common stock, from time to time, at the option of the holder thereof, at a conversion price per share equal to 85% of the volume-weighted average price of our common stock quoted on the OTCQB ® Venture Market operated by OTC Markets Group Inc. over the thirty (30) trading days immediately preceding such date (the “Conversion Price”). The Convertible Note and all accrued interest thereon will be automatically converted into common stock at the Conversion Price on the dated that is five business days prior to the date on which the Company becomes listed on a national securities exchange if all listing requirements have been satisfied by the Company (other than the Company satisfying any stockholders’ equity requirement to be listed on such national exchange).

 

In addition, in connection with the execution of the A&R Credit Agreement and the Convertible Note, the Company issued Mr. Akin 140,185 shares of common stock on November 14, 2022.

 

The foregoing description of the A&R Credit Agreement and Convertible Note does not purport to be complete and is qualified in its entirety by reference to the A&R Credit Agreement and Convertible Note, which fill be filed separately.

 

Item 6. Exhibits

 

Exhibit No.   Description
31.1   Certification by Chief Executive Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002 *
31.2   Certification by Chief Financial Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002 *
32.1   Certification Pursuant to 18 U.S.C. Section 1350 *
10.1   Form of Exercise Notice
10.2   Warrant Offer Letter
10.3   New Warrant
10.4   Securities Purchase Agreement
10.5   Convertible Note
10.6   New Warrant - Convertible
101.INS   Inline XBRL Instance Document *
101.SCH   Inline XBRL Taxonomy Schema Document
101.CAL   Inline XBRL Taxonomy Calculation Linkbase Document *
101.DEF   Inline XBRL Taxonomy Definition Linkbase Document *
101.LAB   Inline XBRL Taxonomy Label Linkbase Document*
101.PRE   Inline XBRL Taxonomy Presentation Linkbase Document *
104   Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

 

* Filed electronically herewith

 

(1) Incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on October 20, 2008, File No. 333-154455

 

(2) Incorporated by reference to the Company’s Current Report on Form 8-K filed December 2, 2011

 

23
Table of Contents 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

 

  Mobivity Holdings Corp.
     
Date: November 14, 2023 By: /s/ Thomas B. Akin
    Thomas B. Akin
    Chairman of the Board of Directors
    (Principal Executive Officer)
     
Date: November 14, 2023 By: /s/ Will Sanchez
    Will Sanchez
    Chief Financial Officer
    (Principal Accounting Officer)

 

24